Literature DB >> 27224882

Prolonged Preoperative Opioid Therapy Associated With Poor Return to Work Rates After Single-Level Cervical Fusion for Radiculopathy for Patients Receiving Workers' Compensation Benefits.

Mhamad Faour1, Joshua T Anderson, Arnold R Haas, Rick Percy, Stephen T Woods, Uri M Ahn, Nicholas U Ahn.   

Abstract

STUDY
DESIGN: Retrospective comparative cohort study.
OBJECTIVE: Examine the effect of prolonged preoperative opioid use on return to work (RTW) status after single-level cervical fusion for radiculopathy. SUMMARY OF BACKGROUND DATA: The use of opioids has a dramatic effect in a workers' compensation population. The costs of claims that involved opioids in the management plan are catastrophic particularly for those undergoing spinal surgical procedure. MATERIALS: Data of patients who underwent single-level cervical fusion for radiculopathy and had received opioid prescriptions before surgery were retrospectively collected from Ohio Bureau of Workers' Compensation between 1993 and 2011 after work-related injury. Then, based on opioid use duration, short-term use (STO) group (<3 mo), intermediate-term use (ITO) group (3-6 mo), and long-term use (LTO) group (>6 mo) were constructed. A multivariate logistic regression analysis was used to determine whether successful RTW status was achieved. Chi-square and analysis of variance tests were used to compare other secondary outcomes after surgery.
RESULTS: Prolonged preoperative opioid use was a negative predictor of successful RTW status (odds ratio = 0.73; 95% confidence interval: 0.55-0.98; P value: 0.04). Prolonged preoperative opioid use was associated with increasingly lower rates of achieving stable RTW status (P < 0.05) and RTW within 1 year after surgery (P < 0.05). The odds of achieving successful RTW status were 0.49 (0.25-0.94) for ITO, and 0.40 (0.24-0.68) for LTO compared with STO group. The odds of RTW less than 1 year after surgery were 0.43 (0.21-0.88) for ITO and 0.36 (0.21-0.62) for LTO compared with STO group. Prolonged preoperative opioid use was also associated with increasingly higher net medical costs (P < 0.01), and disability benefits awarded after surgery (P < 0.01).
CONCLUSION: Prolonged preoperative opioid use was associated with poor functional outcomes after cervical fusion. STO and earlier inclusion of the surgical approach in the management plan may offer better surgical and functional outcomes after cervical fusion. LEVEL OF EVIDENCE: 3.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27224882     DOI: 10.1097/BRS.0000000000001715

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  6 in total

1.  Impact of Preoperative Opioid Use on Total Knee Arthroplasty Outcomes.

Authors:  Savannah R Smith; Jennifer Bido; Jamie E Collins; Heidi Yang; Jeffrey N Katz; Elena Losina
Journal:  J Bone Joint Surg Am       Date:  2017-05-17       Impact factor: 5.284

2.  Opioid use trends in patients undergoing elective thoracic and lumbar spine surgery.

Authors:  Alexandra Stratton; Eugene Wai; Stephen Kingwell; Philippe Phan; Darren Roffey; Mohamed El Koussy; Sean Christie; Peter Jarzem; Parham Rasoulinejad; Steve Casha; Jerome Paquet; Michael Johnson; Edward Abraham; Hamilton Hall; Greg McIntosh; Kenneth Thomas; Raja Rampersaud; Neil Manson; Charles Fisher
Journal:  Can J Surg       Date:  2020-05-28       Impact factor: 2.089

3.  Effect of Preoperative Opiate Use on Outcomes After Posterior Lumbar Surgery.

Authors:  Alex Mierke; Omar Ramos; Jun Chung; Wayne K Cheng; Olumide Danisa
Journal:  Cureus       Date:  2022-02-27

4.  Poorer Preoperative Function Leads to Delayed Return to Work After Anterior Cervical Discectomy and Fusion for Degenerative Cervical Myelopathy.

Authors:  Graham S Goh; Ming Han Lincoln Liow; Zhixing Marcus Ling; Chang-Ming Guo; Wai-Mun Yue; Seang-Beng Tan; John Li-Tat Chen; Reuben Chee Cheong Soh
Journal:  Int J Spine Surg       Date:  2021-12

5.  Preoperative opioid use in patients undergoing shoulder surgery.

Authors:  Vidushan Nadarajah; Sean J Meredith; Julio J Jauregui; Michael P Smuda; Shaun Medina; Mohit N Gilotra; S Ashfaq Hasan; R Frank Henn
Journal:  Shoulder Elbow       Date:  2019-10-17

6.  Tapentadol extended release for the management of chronic neck pain.

Authors:  Domenico Billeci; Flaminia Coluzzi
Journal:  J Pain Res       Date:  2017-03-02       Impact factor: 3.133

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.